PHARMACIE DES PAGODES
ActivePHARMACIE DES PAGODES has been active since 2005 and the Belgian State Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €12k and a net result of €2k. Equity is shrinking by ~31.9% per year across the filed fiscal years. Its solvency ranks better than 10% of 64 sector peers (fiscal year 2025). The computed 12-month bankruptcy probability is 0.4% (very low).
Checked score
Score 2025
54
/ 100
Fair
The score weighs solvency, liquidity and profitability. Bankruptcy probability contributes 35%. Every signal that weighs is under Signals.
Axes · tick = 2024
Profitability70▲+67
Solvency28=
Growth22=
Track record100
Bankruptcy probability, 12 months
0.4%
Very low
0%0.5%1.5%4%10%≥ 25%
Credit up to €500 at 30 days acceptable
Liquidity short (current ratio 0.92 against 0.84 in 2024; short-term debt: 96.8% and cash: 14.5% of total assets), and 97% of the assets are financed with debt.
Credit advice for your own amount and term
Signals
Nine signals. The signal on the left, the evidence on the right.
−lowers risk+raises risk○neutral
lowers risk · Long track record
A company with a long track record statistically fails less often than a young one.
KBO · incorporation dateAge against the risk zone
raises risk · Higher-failure-rate sector
In this sector companies fail more often than the Belgian average.
Gazette · bankruptcies per sector, NACE 21
Relative position
BE, all sectors
reference
Sector 21
higher
← fewer bankruptcies
more bankruptcies →
lowers risk · Annual accounts: healthy financial profile
The latest annual accounts show a healthy profile in solvency, result and liquidity.
NBB · annual accounts 2025Solvency, return and age of the figures
Solvency
3%
Return on assets
0.6%
Age of the figures
9 mo
raises risk · Weak solvency vs sector
Solvency (equity / total assets) is in the sector's weakest quartile: better than 10% of 64 sector peers (2025).
NBB · sector comparisonPosition among 64 sector peers
Solvency
better than 10%
← weakest
strongest →
neutral · Filed after the deadline
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 31-08-2026, 31 days later. For context: 47% of the Belgian market files late and the whole 1-to-90-day band measures 2.0% abnormal legal state against a 1.66% average. We show this as a fact and do not score it.
NBB · 10 filingsDeviation from the deadline
2025
31 d late
2024
29 d late
2023
138 d late
2022
100 d late
2021
211 d late
2020
80 d late
2019
245 d late
← before the deadline
after the deadline →
neutral · The next deadline is still running
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today.
Companies Code · seven monthsPosition in the running window
18-09-2026 today31-12-2026 close31-07-2027 deadline
Financials · fiscal year 2025, full schema
Turnover
€887k▼ 44.0%
2018 · €1.58M
2018: €1.58M
2018 → 2019
EBIT margin
-6.5%▼ 12.8pp
2018 · 6.2%
2018: 6.2%
2018 → 2019
Net result
€2k
2024 · €-44k
2018: €53k
2019: €-66k
2020: €-34k
2021: €-619
2022: €19k
2023: €-36k
2024: €-44k
2018 → 2025
Working capital
€-28k▲ 48.3%
2024 · €-55k
2018: €-22k
2019: €-74k
2020: €-78k
2021: €-50k
2022: €-25k
2023: €-36k
2024: €-55k
2018 → 2025
Multi-year overview
Every figure with its change against the year before
▲ rise
▼ fall
Line20212022202320242025Trend
Equity€89k-€89k▲ 0.7%€53k▼ 40.3%€9k▼ 82.9%€12k▲ 26.6%
Operating result€7k-€27k▲ 261%€14k▼ 48.4%€-44k€8k
Net result€-619-€19k€-36k€-44k▼ 22.8%€2k
Result per fiscal year
Operating resultNet result
The operating result returns to profit in 2025: €8k after a loss of €44k in 2024.
Balance-sheet composition
2025 in colour, 2024 as the grey bar beneath
Assets €383k
Fixed assets
€41k▼ 36.4%
Current assets
€342k▲ 21.2%
Equity and liabilities €383k
Equity
€12k▲ 26.6%
Debt
€372k▲ 10.1%
The debt ratio falls from 97.4% to 97.0%. Equity and debt are higher.
Key figures and ratios
EBITDA
€34k▲
2024 · €-19k
Cash flow
€28k▲
2024 · €-19k
Solvency
3.0%▲
2024 · 2.6%
Current ratio
0.92▲
2024 · 0.84
Quick ratio
0.70▲
2024 · 0.58
Debt / equity
32.17▼
2024 · 36.97
ROE
21.0%▲
2024 · -484.7%
ROA
0.6%▲
2024 · -12.8%
Interest coverage
15.77▲
2024 · -5.68
Debt
€372k▲
2024 · €337k
Debt ≤ 1 year
€371k▲
2024 · €337k
Income taxes
€6k
Staff costs
€118k▼
2024 · €172k
Green means a favourable move, even when the figure itself falls: as with debt or debt / equity.
Filed annual accounts
As filed with the NBB · 2025 against 2024
Balance sheet
Code20242025
Assets
Total assets20/58€346k€383k▲
Fixed assets21/28€64k€41k▼
Intangible fixed assets21€63k€38k▼
Tangible fixed assets22/27-€2k
Plant, machinery and equipment23-€2k
Financial fixed assets28€971€971=
Current assets29/58€283k€342k▲
Stocks and contracts in progress3€86k€85k▼
Stocks30/36€86k€85k▼
Amounts receivable within one year40/41€186k€202k▲
Trade receivables40€78k€107k▲
Other amounts receivable41€107k€95k▼
Cash at bank and in hand54/58€10k€55k▲
Deferred charges and accrued income490/1€650€722▲
Equity and liabilities
Total equity and liabilities10/49€346k€383k▲
Equity10/15€9k€12k▲
Contributions10/11€200k€200k=
Capital10€200k€200k=
Issued capital100€200k€200k=
Reserves13€19k€19k=
Non-distributable reserves130/1€19k€19k=
Legal reserve130€19k€19k=
Profit (loss) carried forward14€-210k€-207k▲
Amounts payable17/49€337k€372k▲
Amounts payable within one year42/48€337k€371k▲
Trade debts44€287k€313k▲
Suppliers440/4€287k€313k▲
Taxes, remuneration and social security45€32k€40k▲
Taxes450/3€3k€10k▲
Remuneration and social security454/9€28k€30k▲
Other amounts payable47/48€18k€18k=
Accrued charges and deferred income492/3€155€835▲
Income statement
Code20242025
Non-recurring operating income76A€9k€3k▼
Remuneration, social security and pensions62€172k€118k▼
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630€25k€26k▲
Other operating charges640/8€717€400▼
Non-recurring operating charges66A€6k-
Gross operating margin9900€159k€152k▼
Operating profit (loss)9901€-44k€8k▲
Financial income75/76B€3k€3k▼
Recurring financial income75€3k€3k▼
Financial charges65/66B€3k€2k▼
Recurring financial charges65€3k€2k▼
Profit (loss) for the period before taxes9903€-44k€8k▲
Income taxes67/77-€6k
Profit (loss) for the period9904€-44k€2k▲
Profit (loss) for the period to be appropriated9905€-44k€2k▲
Appropriation of the result
Profit (loss) to be appropriated9906€-210k€-207k▲
Profit (loss) brought forward from the previous period14P€-166k€-210k▼
Social balance
Average headcount (FTE)90872.41.6▼
The notes to these accounts (11 items: statements of assets and debts, cost breakdowns, rights and commitments) are not shown here.
Timeline · acts, filings and financial milestones
Next filing, fiscal year 2026, expected by
2026
31-08
NBB filing
Annual accounts filed
fiscal year 2025 · full schema · 31 days late
2025
31-12
Financial
Back to profitnet €2k
Net result €2k after 2 loss-making years.
29-08
NBB filing
Annual accounts filed
fiscal year 2024 · full schema · 29 days late
2024
16-12
NBB filing
Annual accounts filed
fiscal year 2023 · full schema · 138 days late
2023
08-11
NBB filing
Annual accounts filed
fiscal year 2022 · full schema · 100 days late
27-02
NBB filing
Annual accounts filed
fiscal year 2021 · full schema · 211 days late
2022
31-12
Financial
Back to profitnet €19k
Net result €19k after 3 loss-making years.
2021
19-10
NBB filing
Annual accounts filed
fiscal year 2020 · full schema · 80 days late
02-04
NBB filing
Annual accounts filed
fiscal year 2019 · full schema · 245 days late
2019
31-12
Financial
Weakest financial yearnet €-66k ▼224%
Net result drops to €-66k, the lowest in the series; recovery starts the following year.
14-11
NBB filing
Annual accounts filed
fiscal year 2018 · full schema · 106 days late
31-01
NBB filing
Annual accounts filed
fiscal year 2017 · full schema · 184 days late
2017
25-08
NBB filing
Annual accounts filed
fiscal year 2016 · full schema · 25 days late
Financial milestoneNBB filingFinancial milestones sit on the fiscal year-end date, not the filing date.
Directors · office · real estate
Directors
10 acts for this company are in the Belgian State Gazette, of which we have read 0. We have therefore not extracted its directors from those acts yet.
Location & real-estate footprint
Registered office, Genappe · 1 establishment unit since 2005
Cannot be placed on the map
This address could not be matched to a point in the Belgian address register (BOSA BEST). The address below comes straight from the Crossroads Bank.
Rue des Lilas 11470 GenappeGround area
1,228 m²
Building footprint
360 m²
Volume, LiDAR
1,169 m³
2 parcels, Brussels, Wallonia · tallest building 13.1 m, ±3 floors. Linked by address, not a title deed.
1 establishment unit
Pharmactivity
since 20052.149.450.813
2 parcels
Wallonia
1
(50%)
Brussels
1
(50%)
| Parcel (capakey) | Region | Area | Buildings | Height / fl. |
|---|---|---|---|---|
| 25113C0175/02E000 | Wallonia | 756 m² | 1 · 232 m² | - |
| 21819C0116/00A004 | Brussels | 472 m² | 1 · 129 m² | 13.1 m · 3 fl. |
Linked by address, not proof of ownership
Methodology
via registered seat: 1 · via establishment units: 1
2 of 2 parcels with an exact address match; the rest are indicative.
Linked through address data, this is not proof of ownership.
Similar companies · same sector, comparable size
SIRON
BE 0894.616.251
Lier · Eq €10k
S-FORM PHARMA
BE 0715.471.307
Etterbeek · Eq €15k
M.D.C.T. BENELUX
BE 0464.081.850
Deinze · Eq €16k
RPO NucleoGenesis
BE 0782.980.238
Gent · Eq €20k
MC Pharma
BE 1022.680.304
Beaumont · Eq €26k
Of 148 companies in sector 21100 we hold annual accounts for 108. 31 are within a factor 10 of this equity.See the whole sector
Company data · Crossroads Bank
Identification
Legal formPublic limited company
Founded05-09-2005
Fiscal year end31-12
Activities, NACEBEL
21100Manufacture of basic pharmaceutical products and pharmaceutical preparations
47730Retail sale of pharmaceutical products
52310
21201Manufacture of basic pharmaceutical products and pharmaceutical preparations
46150Agents in the wholesale of furniture, household goods and hardware
47740Retail trade
47741Retail sale of medical and orthopaedic goods, excluding prescription glasses and lenses
47750Retail sale of cosmetics and toilet articles
51150
52320
Sources
Crossroads Bank for EnterprisesNational Bank · 20 filingsAddress and cadastre registers
Data from official sources, last processed on 16-09-2026. Scores and ratios are computed by Checked and are not a credit decision.